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Finding the Missing Puzzle Piece of Autism
A

utism, one of the greatest mysteries
of medicine – and the most pervasive

Unlocking the hidden mind
Dr. Chugani received a $5.79 million grant from

Her previous studies that treated children with a
drug similar to serotonin improved many of the

development disorder that is characterized

the National Institute of Neurological Disorders

participant’s social interactions and reduced the

by the impairment of social interactions and

and Stroke of the National Institutes of Health for

repetitive behaviors, and this study will further test

communication, severely restricted interest levels

a study that may open doors to finding a treatment

this novel treatment.

and highly repetitive behavior – is prevalent in

for improving those afflicted with autism. This

one to two per 1,000 people. Autism affects many

Autism Center of Excellence Network Grant, “Early

the field of autism,” commented Dr. Joseph Dunbar,

parts of the brain, but how it happens is not clearly

Pharmacotherapy Guided by Biomarkers in Autism,”

associate vice president for Research at Wayne

understood. Signs of autism become noticeable

will continue earlier research which showed that

State University. “Her previous work utilizing PET

in the first three years of a child’s life, and early

the brain serotonergic system is abnormal during

imaging studies has led to the discovery of potential

intervention can help children gain important

critical periods of brain development in children

mechanisms involved in the pathogenesis of autism

social, communication and self-care skills they

with autism.

that may someday lead to new treatments for the

would otherwise lack. There is no single known

Dr. Chugani and her team demonstrated that

cause of autism and there is no cure for the disease

their positron emission tomography (PET) studies

that requires a lifetime of support.

on the serotonin synthesis capacity in children

Dr. Diane Chugani, professor of pediatrics and

younger than six years was significantly altered

radiology at Wayne State University’s School of

when compared to non-autistic children. Serotonin,

Medicine and director of the Translational Imaging

an important factor involved in postnatal

Laboratory at Children’s Hospital of Michigan, is

synaptogenesis – or specialized junctions through

doing research to find the origins and a possible

which neurons signal to each other and other

treatment for autism.

non-neuronal cells to form interconnected circuits
within the central nervous system that are crucial
to the biological processes that underlie perception

“Dr. Chugani is one of the leading scientists in

growing number of children diagnosed with this
complex disability,” he added.

About Dr. Diane Chugani:

Dr. Chugani is a member

of the scientific advisory boards of Autism Speaks and the
Tuberous Sclerosis Alliance. She was a founding board
member of the International Society for Autism Research.
She received her Ph.D.. in pharmacology from the University
of California, Los Angeles and her B.A. (Cum Laude) in
psychology from the University of Maryland, College Park. She
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joined Wayne State University in 1993.

and thought – is thought to be one potential target
to treatment of autism. Through use of the 5HT1A
serotonin agonist, buspirone, in children younger
than six, Chugani hopes to uncover a new and safe
treatment in groups or subgroups of
Dr. Diane Chugani, professor of pediatrics
and radiology

autistic children.
Chugani’s research brings new hope to those
with autism who have difficulty with social skills,
communication and repetitive motor actions.
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